Rots MG - Search Results

1

Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will.

Cano-Rodriguez D, Rots MG. Cano-Rodriguez D, et al. Among authors: rots mg. Curr Genet Med Rep. 2016;4(4):170-179. doi: 10.1007/s40142-016-0104-3. Epub 2016 Oct 1. Curr Genet Med Rep. 2016. PMID: 27933223 Free PMC article. Review.

2

Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes.

de Groote ML, Verschure PJ, Rots MG. de Groote ML, et al. Among authors: rots mg. Nucleic Acids Res. 2012 Nov;40(21):10596-613. doi: 10.1093/nar/gks863. Epub 2012 Sep 21. Nucleic Acids Res. 2012. PMID: 23002135 Free PMC article. Review.

3

Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner.

Cano-Rodriguez D, Gjaltema RA, Jilderda LJ, Jellema P, Dokter-Fokkens J, Ruiters MH, Rots MG. Cano-Rodriguez D, et al. Among authors: rots mg. Nat Commun. 2016 Aug 10;7:12284. doi: 10.1038/ncomms12284. Nat Commun. 2016. PMID: 27506838 Free PMC article.

4

Regulation of mitochondrial gene expression, the epigenetic enigma.

Mposhi A, Van der Wijst MG, Faber KN, Rots MG. Mposhi A, et al. Among authors: rots mg. Front Biosci (Landmark Ed). 2017 Mar 1;22(7):1099-1113. doi: 10.2741/4535. Front Biosci (Landmark Ed). 2017. PMID: 28199194 Free article. Review.

5

Re-expressing Epigenetically Silenced Genes by Inducing DNA Demethylation Through Targeting of Ten-Eleven Translocation 2 to Any Given Genomic Locus.

Rendón JC, Cano-Rodríguez D, Rots MG. Rendón JC, et al. Among authors: rots mg. Methods Mol Biol. 2017;1654:321-335. doi: 10.1007/978-1-4939-7231-9_24. Methods Mol Biol. 2017. PMID: 28986802

6

TCTN2: a novel tumor marker with oncogenic properties.

Cano-Rodriguez D, Campagnoli S, Grandi A, Parri M, Camilli E, Song C, Jin B, Lacombe A, Pierleoni A, Bombaci M, Cordiglieri C, Ruiters MH, Viale G, Terracciano L, Sarmientos P, Abrignani S, Grandi G, Pileri P, Rots MG, Grifantini R. Cano-Rodriguez D, et al. Among authors: rots mg. Oncotarget. 2017 Aug 24;8(56):95256-95269. doi: 10.18632/oncotarget.20438. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221125 Free PMC article.

7

RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis.

Tognoli ML, Vlahov N, Steenbeek S, Grawenda AM, Eyres M, Cano-Rodriguez D, Scrace S, Kartsonaki C, von Kriegsheim A, Willms E, Wood MJ, Rots MG, van Rheenen J, O'Neill E, Pankova D. Tognoli ML, et al. Among authors: rots mg. EMBO J. 2021 Oct 18;40(20):e107680. doi: 10.15252/embj.2021107680. Epub 2021 Sep 17. EMBO J. 2021. PMID: 34532864 Free PMC article.

8

Gene-Targeted DNA Methylation: Towards Long-Lasting Reprogramming of Gene Expression?

Cortés-Mancera FM, Sarno F, Goubert D, Rots MG. Cortés-Mancera FM, et al. Among authors: rots mg. Adv Exp Med Biol. 2022;1389:515-533. doi: 10.1007/978-3-031-11454-0_18. Adv Exp Med Biol. 2022. PMID: 36350521 Review.

9

Modulation of gene expression using zinc finger-based artificial transcription factors.

Stolzenburg S, Bilsland A, Keith WN, Rots MG. Stolzenburg S, et al. Among authors: rots mg. Methods Mol Biol. 2010;649:117-32. doi: 10.1007/978-1-60761-753-2_7. Methods Mol Biol. 2010. PMID: 20680831

10

Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer.

van der Gun BT, de Groote ML, Kazemier HG, Arendzen AJ, Terpstra P, Ruiters MH, McLaughlin PM, Rots MG. van der Gun BT, et al. Among authors: rots mg. Br J Cancer. 2011 Jul 12;105(2):312-9. doi: 10.1038/bjc.2011.231. Epub 2011 Jun 21. Br J Cancer. 2011. PMID: 21694727 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page